These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 29427999)

  • 1. Dissemination of Staphylococcus epidermidis ST22 With Stable, High-Level Resistance to Linezolid and Tedizolid in the Greek-Turkish Region (2008-2016).
    Freitas AR; Dilek AR; Peixe L; Novais C
    Infect Control Hosp Epidemiol; 2018 Apr; 39(4):492-494. PubMed ID: 29427999
    [No Abstract]   [Full Text] [Related]  

  • 2. Dissemination of two international linezolid-resistant Staphylococcus epidermidis clones in Greek hospitals.
    Liakopoulos A; Spiliopoulou I; Damani A; Kanellopoulou M; Schoina S; Papafragas E; Marangos M; Fligou F; Zakynthinos E; Makris D; Protonotariou E; Tsiapara F; Filos K; Diza E; Anastassiou ED; Petinaki E
    J Antimicrob Chemother; 2010 May; 65(5):1070-1. PubMed ID: 20207718
    [No Abstract]   [Full Text] [Related]  

  • 3. An outbreak of colonization with linezolid-resistant Staphylococcus epidermidis in an intensive therapy unit.
    Kelly S; Collins J; Maguire M; Gowing C; Flanagan M; Donnelly M; Murphy PG
    J Antimicrob Chemother; 2008 Apr; 61(4):901-7. PubMed ID: 18272512
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A clone of linezolid-resistant Staphylococcus epidermidis bearing the G2576T mutation is endemic in an Italian hospital.
    Morroni G; Brenciani A; Vincenzi C; Barocci S; Tili E; Manso E; Mingoia M; Menzo S; Varaldo PE; Giovanetti E
    J Hosp Infect; 2016 Oct; 94(2):203-6. PubMed ID: 27546457
    [No Abstract]   [Full Text] [Related]  

  • 5. Dissemination of linezolid-dependent, linezolid-resistant Staphylococcus epidermidis clinical isolates belonging to CC5 in German hospitals.
    Layer F; Vourli S; Karavasilis V; Strommenger B; Dafopoulou K; Tsakris A; Werner G; Pournaras S
    J Antimicrob Chemother; 2018 May; 73(5):1181-1184. PubMed ID: 29360979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit.
    Treviño M; Martínez-Lamas L; Romero-Jung PA; Giráldez JM; Alvarez-Escudero J; Regueiro BJ
    Eur J Clin Microbiol Infect Dis; 2009 May; 28(5):527-33. PubMed ID: 18985396
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissemination of the linezolid-resistant Staphylococcus epidermidis clone ST2 exhibiting the G2576T mutation in the 23S rRNA gene in a tertiary-care hospital, Brazil.
    de Almeida LM; Lincopan N; de Araújo MR; Mamizuka EM
    J Antimicrob Chemother; 2012 Mar; 67(3):768-9. PubMed ID: 22186879
    [No Abstract]   [Full Text] [Related]  

  • 8. Exploring the pharmacodynamic interactions between tedizolid and other orally bioavailable antimicrobials against Staphylococcus aureus and Staphylococcus epidermidis.
    Werth BJ
    J Antimicrob Chemother; 2017 May; 72(5):1410-1414. PubMed ID: 28158617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Linezolid-resistant Staphylococcus epidermidis associated with long-term, repeated linezolid use in a pediatric patient.
    Ishiwada N; Takaya A; Kimura A; Watanabe M; Hino M; Ochiai H; Matsui M; Shibayama K; Yamamoto T
    J Infect Chemother; 2016 Mar; 22(3):187-90. PubMed ID: 26603427
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization and monitoring of linezolid-resistant clinical isolates of Staphylococcus epidermidis in an intensive care unit 4 years after an outbreak of infection by cfr-mediated linezolid-resistant Staphylococcus aureus.
    Baos E; Candel FJ; Merino P; Pena I; Picazo JJ
    Diagn Microbiol Infect Dis; 2013 Jul; 76(3):325-9. PubMed ID: 23726146
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nosocomial outbreak of methicillin- and linezolid-resistant Staphylococcus epidermidis associated with catheter-related infections in intensive care unit patients.
    Seral C; Sáenz Y; Algarate S; Duran E; Luque P; Torres C; Castillo FJ
    Int J Med Microbiol; 2011 Apr; 301(4):354-8. PubMed ID: 21236728
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Linezolid-Resistant Staphylococcus epidermidis, Portugal, 2012.
    Barros M; Branquinho R; Grosso F; Peixe L; Novais C
    Emerg Infect Dis; 2014 May; 20(5):903-5. PubMed ID: 24751182
    [No Abstract]   [Full Text] [Related]  

  • 13. Linezolid resistance in Staphylococcus epidermidis associated with a G2603T mutation in the 23S rRNA gene.
    Lincopan N; de Almeida LM; Elmor de Araújo MR; Mamizuka EM
    Int J Antimicrob Agents; 2009 Sep; 34(3):281-2. PubMed ID: 19376688
    [No Abstract]   [Full Text] [Related]  

  • 14. Activity of linezolid and tedizolid against clinical isolates of methicillin-resistant and methicillin and linezolid resistant Staphylococcus aureus: an in vitro comparison.
    Peñuelas M; Candel FJ; Lejarraga C; López-González L; Viñuela-Prieto JM; López de Mendoza D
    Rev Esp Quimioter; 2016 Oct; 29(5):255-8. PubMed ID: 27374726
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Wide dissemination of linezolid-resistant Staphylococcus epidermidis in Greece is associated with a linezolid-dependent ST22 clone.
    Karavasilis V; Zarkotou O; Panopoulou M; Kachrimanidou M; Themeli-Digalaki K; Stylianakis A; Gennimata V; Ntokou E; Stathopoulos C; Tsakris A; Pournaras S;
    J Antimicrob Chemother; 2015; 70(6):1625-9. PubMed ID: 25712317
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Osteomyelitits due to linezolid-resistant Staphylococcus epidermidis.
    Benefield RJ; Hinde GK; Abolnik IZ
    Clin Infect Dis; 2012 Apr; 54(8):1216-7. PubMed ID: 22337821
    [No Abstract]   [Full Text] [Related]  

  • 17. Incidence, management and outcomes of the first cfr-mediated linezolid-resistant Staphylococcus epidermidis outbreak in a tertiary referral centre in the Republic of Ireland.
    O'Connor C; Powell J; Finnegan C; O'Gorman A; Barrett S; Hopkins KL; Pichon B; Hill R; Power L; Woodford N; Coffey JC; Kearns A; O'Connell NH; Dunne CP
    J Hosp Infect; 2015 Aug; 90(4):316-21. PubMed ID: 25648941
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A T2504A mutation in the 23S rRNA gene responsible for high-level resistance to linezolid of Staphylococcus epidermidis.
    Liakopoulos A; Neocleous C; Klapsa D; Kanellopoulou M; Spiliopoulou I; Mathiopoulos KD; Papafrangas E; Petinaki E
    J Antimicrob Chemother; 2009 Jul; 64(1):206-7. PubMed ID: 19429927
    [No Abstract]   [Full Text] [Related]  

  • 19. An in vitro evaluation of the efficacy of tedizolid: implications for the treatment of skin and soft tissue infections.
    Delpech P; ALeryan M; Jones B; Gemmell C; Lang S
    Diagn Microbiol Infect Dis; 2018 May; 91(1):93-97. PubMed ID: 29452993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Accumulation of multiple mutations in linezolid-resistant Staphylococcus epidermidis causing bloodstream infections; in silico analysis of L3 amino acid substitutions that might confer high-level linezolid resistance.
    Ikonomidis A; Grapsa A; Pavlioglou C; Demiri A; Batarli A; Panopoulou M
    J Chemother; 2016 Dec; 28(6):465-468. PubMed ID: 27077930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.